Company Filing History:
Years Active: 2021-2024
Title: Michael Ehrmann - Innovator in Cyclodepsipeptide Synthesis
Introduction
Michael Ehrmann is a distinguished inventor based in Essen, Germany, known for his contributions to the field of chemical synthesis, particularly in the development of tailored cyclodepsipeptides. With a total of 2 patents to his name, Ehrmann's work focuses on creating potent non-covalent serine protease inhibitors that have significant medical applications.
Latest Patents
Ehrmann's latest patents include an innovative method for the chemical synthesis of Ahp-cyclodepsipeptides. This improved synthesis method allows for straightforward and easy production of tailor-made Ahp-cyclodepsipeptides, which are designed for use as HTRA protease inhibitors. The implications of this invention extend to various medical uses, showcasing the potential impact of his work in therapeutic applications.
Career Highlights
Michael Ehrmann is affiliated with the University of Duisburg-Essen, where he continues to advance research in his field. His expertise in chemical synthesis has positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Throughout his career, Ehrmann has collaborated with notable colleagues, including Markus Kaiser and Steffen Köcher. These partnerships have contributed to the success and innovation of his research projects.
Conclusion
Michael Ehrmann's work in the synthesis of cyclodepsipeptides represents
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.